A medication commonly prescribed for nausea in pregnancy was approved in part based on a 40-year-old study with a major flaw, as revealed by a recent reanalysis of the old study. The drug pyridoxine-doxylamine is sold...
In a commentary published yesterday in Medscape, Dr. John Mandrola argues convincingly that "more than ever we should encourage skepticism and debate among our patients and colleagues. Great scientific results stand on their own" and...
About half of clinical trial results are never published, leaving valuable information unavailable. Every year, thousands of Canadians sign up to participate in clinical trials, offering their bodies to further the development of important medical advances...
This Healthcare Policy essay presents what we believe to be a compelling framework for a renewed national strategy for pharmaceutical policy in Canada. Building on published research and international frameworks, they propose that pharmaceutical policies of federal, provincial, and...